Compounds > tak 779
Page last updated: 2024-09-05

tak 779 and triazoles

tak 779 has been researched along with triazoles in 8 studies

Compound Research Comparison

Studies
(tak 779)		Trials
(tak 779)		Recent Studies (post-2010)
(tak 779)		Studies
(triazoles)		Trials
(triazoles)		Recent Studies (post-2010) (triazoles)
11813525,8082,25213,501

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, M; Saita, Y; Shimizu, Y1
Dioszegi, M; Ji, C; Kondru, R; Mirzadegan, T; Rotstein, D; Sankuratri, S; Zhang, J1
Arenzana-Seisdedos, F1
Armand-Ugón, M; Ballana, E; Clotet, B; Esté, JA; Gonzalez, E; Mena, M; Moncunill, G1
Hu, Q; Huang, X; Shattock, RJ1
Henrich, TJ; Konstantinidis, I; Kuritzkes, DR; Leopold, KE; Lewine, NR; Sagar, M; Tsibris, AM1
Antunes, F; Barroso, H; Bártolo, I; Borrego, P; Caixas, U; Calado, R; Cavaco-Silva, P; Doroana, M; Maltez, F; Marcelino, JM; Rocha, C; Taveira, N1
Chen, L; Chen, Z; Cheung, AK; Kang, Y; Lau, TC; Li, B; Li, S; Liang, J; Liu, L; Lu, X; Ng, J; Tan, Z; Wang, H; Wu, Z; Zheng, B1

Reviews

1 review(s) available for tak 779 and triazoles

ArticleYear
[Viral entry as therapeutic target. Current situation of entry inhibitors].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 11

    Topics: Adult; Amides; Benzoates; CCR5 Receptor Antagonists; CD4 Antigens; Chemokines, CC; Chemokines, CXC; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Membrane Fusion; Models, Molecular; Piperazines; Pyrimidines; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, CXCR4; Spiro Compounds; Structure-Activity Relationship; Triazoles; Virus Attachment; Virus Internalization

2008

Other Studies

7 other study(ies) available for tak 779 and triazoles

ArticleYear
Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor.
    International immunopharmacology, 2007, Dec-05, Volume: 7, Issue:12

    Topics: Amides; Amino Acid Sequence; Amino Acid Substitution; Animals; Binding, Competitive; Calcium; CCR5 Receptor Antagonists; Cell Line; Cell Membrane; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Cyclic N-Oxides; Cyclohexanes; HIV Fusion Inhibitors; Humans; Macaca mulatta; Maraviroc; Mice; Molecular Sequence Data; Oximes; Piperidines; Precursor Cells, B-Lymphoid; Pyridines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Species Specificity; Transfection; Triazoles

2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Molecular pharmacology, 2008, Volume: 73, Issue:3

    Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; Benzoates; Binding Sites; CCR5 Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Maraviroc; Membrane Fusion; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Piperazines; Piperidines; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Spiro Compounds; Static Electricity; Transfection; Triazoles

2008
Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3

    Topics: Amides; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Cells, Cultured; Cyclohexanes; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV-1; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Maraviroc; Microbial Sensitivity Tests; Quaternary Ammonium Compounds; Triazoles

2010
C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors.
    The Journal of general virology, 2010, Volume: 91, Issue:Pt 12

    Topics: Amides; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Cyclohexanes; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV-1; Humans; Maraviroc; Protein Binding; Pyrazoles; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, HIV; Triazoles; Valine; Virus Internalization

2010
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.
    Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 55, Issue:4

    Topics: Amides; Amino Acid Sequence; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; Evolution, Molecular; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Maraviroc; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Peptide Fragments; Piperazines; Pyrimidines; Quaternary Ammonium Compounds; Receptors, CCR5; Triazoles

2010
Baseline susceptibility of primary HIV-2 to entry inhibitors.
    Antiviral therapy, 2012, Volume: 17, Issue:3

    Topics: Amides; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Male; Maraviroc; Microbial Sensitivity Tests; Peptide Fragments; Quaternary Ammonium Compounds; Triazoles

2012
CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.
    The Journal of biological chemistry, 2012, May-11, Volume: 287, Issue:20

    Topics: Amides; Anti-HIV Agents; Binding Sites; CCR5 Receptor Antagonists; Cell Line; Cyclohexanes; HIV Infections; HIV-1; Humans; Maraviroc; Protein Structure, Secondary; Quaternary Ammonium Compounds; Receptors, CCR5; Sulfonamides; Triazoles; Tropanes; Virus Internalization; Virus Replication

2012